• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

含有两性霉素B的聚合磷脂囊泡:体外毒性和抗真菌活性评估

Polymerized phospholipid vesicles containing amphotericin B: evaluation of toxic and antifungal activities in vitro.

作者信息

Mehta R, Hsu M J, Juliano R L, Krause H J, Regen S L

出版信息

J Pharm Sci. 1986 Jun;75(6):579-81. doi: 10.1002/jps.2600750611.

DOI:10.1002/jps.2600750611
PMID:3525815
Abstract

We have prepared lipid vesicles (liposomes) composed of polymerized bis[12-(methacryloyloxy)dodecanoyl]-L-alpha-phosphatidylcholine (DPL) which contain the antifungal polyene antibiotic amphotericin B (AMB). It was necessary to devise a novel method for incorporating AMB into the liposomes subsequent to polymerization. The polymer liposome AMB was as effective as AMB in "conventional" liposomes in terms of inhibiting fungal growth in vitro. However, in contrast to "conventional" liposomes, the polymerized DPL vesicles did not protect mammalian cells against AMB induced toxicity.

摘要

我们制备了由聚合的双[12-(甲基丙烯酰氧基)十二烷酰基]-L-α-磷脂酰胆碱(DPL)组成的脂质囊泡(脂质体),其包含抗真菌多烯抗生素两性霉素B(AMB)。有必要设计一种在聚合后将AMB掺入脂质体的新方法。就体外抑制真菌生长而言,聚合物脂质体AMB与“常规”脂质体中的AMB一样有效。然而,与“常规”脂质体不同,聚合的DPL囊泡不能保护哺乳动物细胞免受AMB诱导的毒性。

相似文献

1
Polymerized phospholipid vesicles containing amphotericin B: evaluation of toxic and antifungal activities in vitro.含有两性霉素B的聚合磷脂囊泡:体外毒性和抗真菌活性评估
J Pharm Sci. 1986 Jun;75(6):579-81. doi: 10.1002/jps.2600750611.
2
Hemolytic and antifungal activity of liposome-entrapped amphotericin B prepared by the precipitation method.沉淀法制备的脂质体包封两性霉素B的溶血和抗真菌活性
Pharm Dev Technol. 1997 Aug;2(3):275-84. doi: 10.3109/10837459709031447.
3
Mechanism of the selective toxicity of amphotericin B incorporated into liposomes.两性霉素B载入脂质体后的选择性毒性机制。
Mol Pharmacol. 1987 Jan;31(1):1-11.
4
Comparative in vitro studies on liposomal formulations of amphotericin B and its derivative, N-methyl-N-D-fructosyl amphotericin B methyl ester (MFAME).两性霉素B及其衍生物N-甲基-N-D-果糖基两性霉素B甲酯(MFAME)脂质体制剂的体外比较研究。
Acta Biochim Pol. 2002;49(1):67-75.
5
Interactions of liposome-incorporated amphotericin B with kidney epithelial cell cultures.脂质体包裹的两性霉素B与肾上皮细胞培养物的相互作用。
Mol Pharmacol. 1988 Sep;34(3):286-97.
6
Influence of phospholipid/amphotericin B ratio and phospholipid type on in vitro renal cell toxicities and fungicidal activities of lipid-associated amphotericin B formulations.磷脂/两性霉素B比例及磷脂类型对脂质体两性霉素B制剂体外肾细胞毒性和杀菌活性的影响。
Antimicrob Agents Chemother. 1992 Feb;36(2):262-6. doi: 10.1128/AAC.36.2.262.
7
Affinity of amphotericin B for phosphatidylcholine vesicles as a determinant of the in vitro cellular toxicity of liposomal preparations.两性霉素B对磷脂酰胆碱囊泡的亲和力作为脂质体制剂体外细胞毒性的一个决定因素。
Biochim Biophys Acta. 1990 Jan 15;1021(1):39-45. doi: 10.1016/0005-2736(90)90381-w.
8
Preparation by spray drying of amphotericin B-phospholipid composite particles and their anticellular activity.两性霉素B-磷脂复合颗粒的喷雾干燥制备及其抗细胞活性
Drug Deliv. 2001 Jul-Aug;8(3):143-7. doi: 10.1080/107175401316906900.
9
Release of amphotericin B from delivery systems and its action against fungal and mammalian cells.
J Drug Target. 1997;4(5):311-9. doi: 10.3109/10611869708995847.
10
Assessment of in vitro antifungal efficacy and in vivo toxicity of Amphotericin B-loaded PLGA and PLGA-PEG blend nanoparticles.载两性霉素 B 的 PLGA 和 PLGA-PEG 共混纳米粒的体外抗真菌功效和体内毒性评估。
J Mycol Med. 2017 Dec;27(4):519-529. doi: 10.1016/j.mycmed.2017.07.004. Epub 2017 Aug 8.